Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review

For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is respon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood reviews 2019-05, Vol.35, p.32-42
Hauptverfasser: Leitão Guerra, Ricardo Luz, Leitão Guerra, Cezar Luz, Bastos, Mariana Gouveia, de Oliveira, André Hasler Príncipe, Salles, Cristina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 42
container_issue
container_start_page 32
container_title Blood reviews
container_volume 35
creator Leitão Guerra, Ricardo Luz
Leitão Guerra, Cezar Luz
Bastos, Mariana Gouveia
de Oliveira, André Hasler Príncipe
Salles, Cristina
description For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed.
doi_str_mv 10.1016/j.blre.2019.03.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2190120671</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0268960X1830119X</els_id><sourcerecordid>2190120671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</originalsourceid><addsrcrecordid>eNp9kE1P3DAURa2KCqbAH-gCeckm6bONnaRig0b9kpC6gKrsLI_zMuMhiYPtMJp_30QzZcnKb3Hute4h5DODnAFTX7b5qg2Yc2BVDiIHYB_IgknBM6ZKdkIWwFWZVQqezsinGLcAUAlVnJIzAaXkIIsFiQ_OPrdILbYtDZhc7weTNvuv9O_GJLpD2vsdHfsaQ0ymr-kYXb-mfkjOmpZav8GAvUWafOfXwQybPTX92h3vnN7RuI8JOzMFpg9eHe4uyMfGtBEvj-85-fP92-PyZ3b_-8ev5d19ZoVUKVOK1ZIrVgnDm5LJhgtbIKgSLZdWNQW_QQtyVUPJbmzRcL4ytmy4MRVIW5TinFwfeofgX0aMSXcuzkNNj36MmrMKGAdVsAnlB9QGH2PARg_BdSbsNQM9y9ZbPcvWs2wNQk-yp9DVsX9cdVi_Rf7bnYDbA4DTyml50NG62VbtAtqka-_e6_8HbbeSLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2190120671</pqid></control><display><type>article</type><title>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</title><source>Access via ScienceDirect (Elsevier)</source><creator>Leitão Guerra, Ricardo Luz ; Leitão Guerra, Cezar Luz ; Bastos, Mariana Gouveia ; de Oliveira, André Hasler Príncipe ; Salles, Cristina</creator><creatorcontrib>Leitão Guerra, Ricardo Luz ; Leitão Guerra, Cezar Luz ; Bastos, Mariana Gouveia ; de Oliveira, André Hasler Príncipe ; Salles, Cristina</creatorcontrib><description>For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed.</description><identifier>ISSN: 0268-960X</identifier><identifier>EISSN: 1532-1681</identifier><identifier>DOI: 10.1016/j.blre.2019.03.001</identifier><identifier>PMID: 30852057</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>OCT angiography ; Optical coherence tomography angiography ; Sickle cell anemia ; Sickle cell disease ; Sickle cell maculopathy ; Sickle cell retinopathy</subject><ispartof>Blood reviews, 2019-05, Vol.35, p.32-42</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</citedby><cites>FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.blre.2019.03.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30852057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leitão Guerra, Ricardo Luz</creatorcontrib><creatorcontrib>Leitão Guerra, Cezar Luz</creatorcontrib><creatorcontrib>Bastos, Mariana Gouveia</creatorcontrib><creatorcontrib>de Oliveira, André Hasler Príncipe</creatorcontrib><creatorcontrib>Salles, Cristina</creatorcontrib><title>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</title><title>Blood reviews</title><addtitle>Blood Rev</addtitle><description>For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed.</description><subject>OCT angiography</subject><subject>Optical coherence tomography angiography</subject><subject>Sickle cell anemia</subject><subject>Sickle cell disease</subject><subject>Sickle cell maculopathy</subject><subject>Sickle cell retinopathy</subject><issn>0268-960X</issn><issn>1532-1681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P3DAURa2KCqbAH-gCeckm6bONnaRig0b9kpC6gKrsLI_zMuMhiYPtMJp_30QzZcnKb3Hute4h5DODnAFTX7b5qg2Yc2BVDiIHYB_IgknBM6ZKdkIWwFWZVQqezsinGLcAUAlVnJIzAaXkIIsFiQ_OPrdILbYtDZhc7weTNvuv9O_GJLpD2vsdHfsaQ0ymr-kYXb-mfkjOmpZav8GAvUWafOfXwQybPTX92h3vnN7RuI8JOzMFpg9eHe4uyMfGtBEvj-85-fP92-PyZ3b_-8ev5d19ZoVUKVOK1ZIrVgnDm5LJhgtbIKgSLZdWNQW_QQtyVUPJbmzRcL4ytmy4MRVIW5TinFwfeofgX0aMSXcuzkNNj36MmrMKGAdVsAnlB9QGH2PARg_BdSbsNQM9y9ZbPcvWs2wNQk-yp9DVsX9cdVi_Rf7bnYDbA4DTyml50NG62VbtAtqka-_e6_8HbbeSLw</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Leitão Guerra, Ricardo Luz</creator><creator>Leitão Guerra, Cezar Luz</creator><creator>Bastos, Mariana Gouveia</creator><creator>de Oliveira, André Hasler Príncipe</creator><creator>Salles, Cristina</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190501</creationdate><title>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</title><author>Leitão Guerra, Ricardo Luz ; Leitão Guerra, Cezar Luz ; Bastos, Mariana Gouveia ; de Oliveira, André Hasler Príncipe ; Salles, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>OCT angiography</topic><topic>Optical coherence tomography angiography</topic><topic>Sickle cell anemia</topic><topic>Sickle cell disease</topic><topic>Sickle cell maculopathy</topic><topic>Sickle cell retinopathy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leitão Guerra, Ricardo Luz</creatorcontrib><creatorcontrib>Leitão Guerra, Cezar Luz</creatorcontrib><creatorcontrib>Bastos, Mariana Gouveia</creatorcontrib><creatorcontrib>de Oliveira, André Hasler Príncipe</creatorcontrib><creatorcontrib>Salles, Cristina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leitão Guerra, Ricardo Luz</au><au>Leitão Guerra, Cezar Luz</au><au>Bastos, Mariana Gouveia</au><au>de Oliveira, André Hasler Príncipe</au><au>Salles, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</atitle><jtitle>Blood reviews</jtitle><addtitle>Blood Rev</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>35</volume><spage>32</spage><epage>42</epage><pages>32-42</pages><issn>0268-960X</issn><eissn>1532-1681</eissn><abstract>For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30852057</pmid><doi>10.1016/j.blre.2019.03.001</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0268-960X
ispartof Blood reviews, 2019-05, Vol.35, p.32-42
issn 0268-960X
1532-1681
language eng
recordid cdi_proquest_miscellaneous_2190120671
source Access via ScienceDirect (Elsevier)
subjects OCT angiography
Optical coherence tomography angiography
Sickle cell anemia
Sickle cell disease
Sickle cell maculopathy
Sickle cell retinopathy
title Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A39%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sickle%20cell%20retinopathy:%20What%20we%20now%20understand%20using%20optical%20coherence%20tomography%20angiography.%20A%20systematic%20review&rft.jtitle=Blood%20reviews&rft.au=Leit%C3%A3o%20Guerra,%20Ricardo%20Luz&rft.date=2019-05-01&rft.volume=35&rft.spage=32&rft.epage=42&rft.pages=32-42&rft.issn=0268-960X&rft.eissn=1532-1681&rft_id=info:doi/10.1016/j.blre.2019.03.001&rft_dat=%3Cproquest_cross%3E2190120671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2190120671&rft_id=info:pmid/30852057&rft_els_id=S0268960X1830119X&rfr_iscdi=true